KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Hologic (HOLX) EBT Margin (2016 - 2025)

Historic EBT Margin for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to 21.92%.

  • Hologic's EBT Margin fell 23000.0% to 21.92% in Q4 2025 from the same period last year, while for Dec 2025 it was 16.08%, marking a year-over-year decrease of 67300.0%. This contributed to the annual value of 16.61% for FY2025, which is 48500.0% down from last year.
  • Hologic's EBT Margin amounted to 21.92% in Q4 2025, which was down 23000.0% from 21.65% recorded in Q3 2025.
  • Hologic's EBT Margin's 5-year high stood at 50.76% during Q1 2021, with a 5-year trough of 2.83% in Q1 2025.
  • Its 5-year average for EBT Margin is 23.64%, with a median of 22.69% in 2025.
  • In the last 5 years, Hologic's EBT Margin surged by 350400bps in 2021 and then plummeted by -236200bps in 2025.
  • Over the past 5 years, Hologic's EBT Margin (Quarter) stood at 42.27% in 2021, then plummeted by -47bps to 22.26% in 2022, then dropped by -15bps to 18.88% in 2023, then rose by 28bps to 24.22% in 2024, then fell by -9bps to 21.92% in 2025.
  • Its EBT Margin stands at 21.92% for Q4 2025, versus 21.65% for Q3 2025 and 22.95% for Q2 2025.